Geron Corporation (GERN) News

Geron Corporation (GERN): $1.27

-0.03 (-2.31%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add GERN to Watchlist
Sign Up

Industry: Biotech


Ranked

of 392

in industry

Filter GERN News Items

GERN News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

GERN News Highlights

  • GERN's 30 day story count now stands at 2.
  • Over the past 23 days, the trend for GERN's stories per day has been choppy and unclear. It has oscillated between 1 and 1.

Latest GERN News From Around the Web

Below are the latest news stories about Geron Corp that investors may wish to consider to help them evaluate GERN as an investment opportunity.

Geron: Just One More Year Of Patience, Then Decision Time

Just when I thought Geron (GERN) could not go down any further, I see it is down 42% since my last coverage in June. That is sad, because in imetelstat Geron has one of the most promising, pioneering cancer technology in the sector, and yet, despite all its promise, the...

Avisol Capital Partners on Seeking Alpha | February 23, 2022

Could The Geron Corporation (NASDAQ:GERN) Ownership Structure Tell Us Something Useful?

Every investor in Geron Corporation ( NASDAQ:GERN ) should be aware of the most powerful shareholder groups. Large...

Yahoo | January 31, 2022

Geron (GERN) Investor Presentation - Slideshow

No summary available.

Seeking Alpha | January 28, 2022

Karyopharm's (KPTI) Eltanexor Gets Orphan Drug Tag for MDS

The FDA bestows an Orphan Drug status to Karyopharm's (KPTI) investigational candidate, eltanexor, for treating myelodysplastic syndromes.

Yahoo | January 26, 2022

Geron to Present at the B. Riley Securities Virtual Oncology Investor Conference

FOSTER CITY, Calif., January 21, 2022--Geron to Present at the B. Riley Securities Virtual Oncology Investor Conference

Yahoo | January 21, 2022

Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

FOSTER CITY, Calif., January 20, 2022--Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Yahoo | January 20, 2022

Geron to Present at the H.C. Wainwright BioConnect Conference

FOSTER CITY, Calif., January 04, 2022--Geron to Present at the H.C. Wainwright BioConnect Conference

Yahoo | January 4, 2022

Parametric Portfolio Associates LLC Has $237,000 Holdings in Geron Co. (NASDAQ:GERN)

Parametric Portfolio Associates LLC increased its stake in Geron Co. (NASDAQ:GERN) by 76.1% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 167,920 shares of the biopharmaceutical companys stock after buying an additional 72,571 shares during the quarter. Parametric Portfolio Associates []

Dakota Financial News | December 24, 2021

Geron Corporation (GERN) Falls -1.49%, Causing Bears To Lose

Geron Corporation (NASDAQ:GERN) has a beta value of 1.06 and has seen 1.85 million shares traded in the last trading session. The company, currently valued at $415.51M, closed the last trade at $1.32 per share which meant it lost -$0.02 on the day or -1.49% during that session. The GERN stock price is -78.79% off Geron Corporation (GERN) Falls -1.49%, Causing Bears To Lose Read More »

Marketing Sentinel | December 22, 2021

Geron Corporation 2021 Q2 - Results - Earnings Call Presentation

No summary available.

Seeking Alpha | December 14, 2021


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.8669 seconds.